Skip to content

FARMA V.T.B.: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

FARMA V.T.B.

BE 0446.285.023
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€117,361
2024 · €147,129-€29,768
Equity
€170,167
2024 · €139,806+€30,361
Cash
€136,083
2024 · €128,299+€7,784
Balance sheet total
€456,718
2024 · €453,433+€3,286

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€21,247

    down €21,247 (-13.9%), from €152,801 to €131,554

    of which Trade receivables: -€28,551

  • Cash +€7,784

    up €7,784 (+6.1%), from €128,299 to €136,083

    mainly Net result for the year (+€117,361) and Receivables within one year (+€21,247)

  • Stocks and contracts +€7,586

    up €7,586 (+5.8%), from €130,705 to €138,291

  • Tangible fixed assets +€5,452

    up €5,452 (+16.8%), from €32,369 to €37,821

    of which Plant, machinery and equipment: +€7,100

Equity and liabilities
  • Reserves +€30,361

    up €30,361 (+25.0%), from €121,214 to €151,575

  • Other debts -€15,242

    down €15,242 (-7.1%), from €214,452 to €199,210

  • Trade debts -€12,132

    down €12,132 (-14.3%), from €84,945 to €72,814

Income statement
  • Gross operating margin -€36,013

    down €36,013 (-14.7%), from €245,566 to €209,553

  • Taxes -€6,215

    down €6,215 (-38.3%), from €16,242 to €10,028

  • Staff costs +€2,771

    up €2,771 (+4.0%), from €69,211 to €71,982

  • Depreciation -€2,679

    down €2,679 (-24.7%), from €10,862 to €8,182

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €147,129
Gross operating margin -€36,013
Staff costs -€2,771
Depreciation +€2,679
Other operating charges +€77
Financial income +€604
Financial charges -€560
Taxes +€6,215
Result 2025 €117,361
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€112,039
Investment -€17,255
Financing -€87,000
Cash 2024 €128,299
Net result for the year +€117,361
Depreciation +€8,182
Stocks and contracts -€7,586
Receivables within one year +€21,247
Deferred charges and accrued income -€90
Trade debts -€12,132
Tax, wage and social debts +€298
Other debts -€15,242
Investment in fixed assets (net) -€17,255
Contributions, distributions and other -€87,000
Cash 2025 €136,083
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €453,433 €456,718 +€3,286 +0.7%
Fixed assets 21/28 €37,455 €46,528 +€9,072 +24.2%
Tangible fixed assets 22/27 €32,369 €37,821 +€5,452 +16.8%
Land and buildings 22 €24,673 €23,025 -€1,648 -6.7%
Plant, machinery and equipment 23 €7,696 €14,796 +€7,100 +92.3%
Financial fixed assets 28 €5,087 €8,707 +€3,620 +71.2%
Current assets 29/58 €415,977 €410,191 -€5,787 -1.4%
Stocks and contracts in progress 3 €130,705 €138,291 +€7,586 +5.8%
Stocks 30/36 €130,705 €138,291 +€7,586 +5.8%
Amounts receivable within one year 40/41 €152,801 €131,554 -€21,247 -13.9%
Trade receivables 40 €148,911 €120,360 -€28,551 -19.2%
Other amounts receivable 41 €3,890 €11,194 +€7,304 +188%
Cash at bank and in hand 54/58 €128,299 €136,083 +€7,784 +6.1%
Deferred charges and accrued income 490/1 €4,173 €4,263 +€90 +2.2%
Total equity and liabilities 10/49 €453,433 €456,718 +€3,286 +0.7%
Equity 10/15 €139,806 €170,167 +€30,361 +21.7%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €121,214 €151,575 +€30,361 +25.0%
Distributable reserves 133 €121,214 €151,575 +€30,361 +25.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €313,627 €286,551 -€27,076 -8.6%
Amounts payable within one year 42/48 €313,627 €286,551 -€27,076 -8.6%
Trade debts 44 €84,945 €72,814 -€12,132 -14.3%
Suppliers 440/4 €84,945 €72,814 -€12,132 -14.3%
Taxes, remuneration and social security 45 €14,229 €14,528 +€298 +2.1%
Taxes 450/3 €5,242 €5,270 +€28 +0.5%
Remuneration and social security 454/9 €8,987 €9,258 +€271 +3.0%
Other amounts payable 47/48 €214,452 €199,210 -€15,242 -7.1%
Remuneration, social security and pensions 62 €69,211 €71,982 +€2,771 +4.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €10,862 €8,182 -€2,679 -24.7%
Other operating charges 640/8 €997 €920 -€77 -7.7%
Gross operating margin 9900 €245,566 €209,553 -€36,013 -14.7%
Operating profit (loss) 9901 €164,497 €128,469 -€36,028 -21.9%
Financial income 75/76B €370 €974 +€604 +163%
Recurring financial income 75 €370 €974 +€604 +163%
Financial charges 65/66B €1,495 €2,054 +€560 +37.4%
Recurring financial charges 65 €1,495 €2,054 +€560 +37.4%
Profit (loss) for the period before taxes 9903 €163,372 €127,389 -€35,983 -22.0%
Income taxes 67/77 €16,242 €10,028 -€6,215 -38.3%
Profit (loss) for the period 9904 €147,129 €117,361 -€29,768 -20.2%
Profit (loss) for the period to be appropriated 9905 €147,129 €117,361 -€29,768 -20.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.